Calcium spirulan

Drug Profile

Calcium spirulan

Alternative Names: Ca-SP

Latest Information Update: 23 Apr 2003

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nippon Oil Corporation
  • Class Antivirals
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Cytomegalovirus infections; Herpes simplex virus infections; HIV-1 infections

Most Recent Events

  • 27 Jun 2002 Nippon Mitsubishi Oil Corporation is now called Nippon Oil Corporation
  • 09 Oct 2000 Profile reviewed. Patent numbers have been added
  • 12 Nov 1996 Preclinical development for Cytomegalovirus infections in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top